Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Provention Bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 112 | −2 |
| Shares | 22.3M | 689 | 23.7M | +1.37M (+6.2%) |
| Value | $142.9M | $4.00K | $133.0M | −$9.86M (−6.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Provention Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Panagora Asset Management Inc | 45,986 | $258.0K | 0.00% |
| Aristides Capital LLC | 35,256 | $198.0K | 0.11% |
| Dimensional Fund Advisors LP | 32,131 | $181.0K | 0.00% |
| Parallax Volatility Advisers, L.P. | 30,177 | $170.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 27,844 | $156.0K | 0.02% |
| Prudential Financial Inc | 25,300 | $142.0K | 0.00% |
| PDT Partners, LLC | 21,786 | $122.0K | 0.01% |
| Caxton Associates LP | 21,198 | $119.0K | 0.02% |
| Graham Capital Management, L.P. | 20,577 | $115.0K | 0.01% |
| Algert Global LLC | 18,150 | $102.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 17,993 | $101.0K | 0.00% |
| Alpine Global Management, LLC | 16,074 | $90.0K | 0.01% |
| Ensign Peak Advisors, Inc | 14,570 | $82.0K | 0.00% |
| J.W. Cole Advisors, Inc. | 13,000 | $73.0K | 0.00% |
| Wolverine Trading, LLC | 10,661 | $61.0K | 0.00% |
| Denali Advisors LLC | 7,000 | $39.0K | 0.01% |
| Reilly Financial Advisors, LLC | 200 | $1.00K | 0.00% |
| Toronto Dominion Bank | 6 | $0 | 0.00% |
| CWM, LLC | 62 | $0 | 0.00% |
| Edge Wealth Management LLC | 50 | – | – |
Sold out (22)
Institutions that held Provention Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| 683 Capital Management, LLC | 198,429 | $1.27M |
| Two Sigma Investments, LP | 93,600 | $599.0K |
| Barclays PLC | 77,683 | $497.0K |
| State of Wisconsin Investment Board | 67,100 | $429.0K |
| Ghost Tree Capital, LLC | 50,000 | $320.0K |
| Vontobel Holding Ltd. | 30,000 | $192.0K |
| HighTower Advisors, LLC | 23,616 | $151.0K |
| HSBC Holdings PLC | 23,352 | $150.0K |
| Jump Financial, LLC | 22,600 | $145.0K |
| Rafferty Asset Management, LLC | 21,440 | $137.0K |
| NinePointTwo Capital | 21,077 | $134.0K |
| DekaBank Deutsche Girozentrale | 20,000 | $126.0K |
| Franklin Resources Inc | 15,401 | $98.0K |
| Principal Financial Group Inc | 12,587 | $81.0K |
| Invst, LLC | 11,800 | $76.0K |
| Engineers Gate Manager LP | 11,369 | $73.0K |
| Harbour Investments, Inc. | 5,260 | $34.0K |
| Penserra Capital Management LLC | 1,450 | $9.00K |
| Aspire Private Capital, LLC | 300 | $2.00K |
| Column Capital Advisors, LLC | 152 | $1.00K |
| IFP Advisors, Inc | 42 | – |
| Gerber Kawasaki Wealth & Investment Management | 3 | – |
Not filed for Q4 2021 yet (1)
Institutions that held Provention Bio, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 689 | $4.00K |